Literature DB >> 6277475

Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.

R J Frampton, L J Suva, J A Eisman, D M Findlay, G E Moore, J M Moseley, T J Martin.   

Abstract

Receptors for 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] have been described in several human breast cancer cell lines and more recently in human melanoma. The presence of 1,25-(OH)2D3 receptor (1,25-DR) in two cultured breast cancer cell lines was associated with receptors for calcitonin, another hormone thought to have effects on calcium handling. Therefore, it seemed important to examine a range of established human cancer cell lines for the presence of receptors for 1,25-(OH)2D3 and calcitonin. Thirty-three cancer cell lines were examined. 1,25-DR was found to be present in 23 lines, while calcitonin receptors were not detected in any of them. The 1,25-DR from several cell lines sedimented at about 3.5S in sucrose density gradients, had the appropriate specificity for vitamin D metabolites, had Kds of 0.8 to 2.2 x 10(-11) M, and had receptor concentrations of 12 to 99 fmol/mg protein. Ten malignant melanoma and nine colonic carcinoma lines constituted the largest groups of carcinoma cell lines, and seven and eight, respectively, of these were 1,25-DR positive. The high frequency of 1,25-DR positivity in the cultured colonic carcinoma cells is quite different from the low frequency of 1,25-DR in primary colonic carcinomas. It was also interesting that both of two cell lines derived from patients who had had both bone metastases and malignant hypercalcemia were 1,25-DR positive. These various cell lines may provide useful models for the examination of 1,25-(OH)2D3 action in vitro.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277475

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Minireview: Vitamin D: is there a role in extraskeletal health?

Authors:  Sylvia Christakos; Hector F DeLuca
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

2.  Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.

Authors:  Jamila Al-Azhri; Yali Zhang; Wiam Bshara; Gary Zirpoli; Susan E McCann; Thaer Khoury; Carl D Morrison; Stephen B Edge; Christine B Ambrosone; Song Yao
Journal:  Clin Cancer Res       Date:  2016-07-12       Impact factor: 12.531

3.  Vitamin D: a hormone for all seasons--how much is enough?

Authors:  Howard A Morris
Journal:  Clin Biochem Rev       Date:  2005-02

4.  The association between vitamin D receptor expression and prolonged overall survival in breast cancer.

Authors:  Nina Ditsch; Bettina Toth; Doris Mayr; Miriam Lenhard; Julia Gallwas; Tobias Weissenbacher; Christian Dannecker; Klaus Friese; Udo Jeschke
Journal:  J Histochem Cytochem       Date:  2011-11-21       Impact factor: 2.479

Review 5.  The regulatory role of miRNAs on VDR in breast cancer.

Authors:  Tatyana Singh; Brian D Adams
Journal:  Transcription       Date:  2017-06-09

Review 6.  Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells.

Authors:  Donald Matthews; Erika LaPorta; Glendon M Zinser; Carmen J Narvaez; Joellen Welsh
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-20       Impact factor: 4.292

7.  The effect of 1, 25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor.

Authors:  M Shabahang; A E Buffan; J M Nolla; L M Schumaker; R V Brenner; R R Buras; R J Nauta; S R Evans
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

Review 8.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

9.  Combined effects of 1,25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells.

Authors:  T Vink-van Wijngaarden; H A Pols; C J Buurman; J C Birkenhäger; J P van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

Review 10.  Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways.

Authors:  Qiang Shen; Powel H Brown
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.